Trial Profile
TAHOE: Sustained InTravitreal DexAmetHasone Implant (Ozurdex) for Uveitic Macular Edema
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Jan 2018
Price :
$35
*
At a glance
- Drugs Dexamethasone (Primary)
- Indications Retinal oedema; Uveitis
- Focus Therapeutic Use
- Acronyms TAHOE
- 10 Mar 2015 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
- 16 Jul 2014 New trial record